2012-10-04 07:52:22 - New Pharmaceuticals market report from Global Markets Direct: "Cytos Biotechnology AG - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Cytos Biotechnology AG - Product Pipeline Review - 2012" provides data on the Cytos Biotechnology AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Cytos Biotechnology AG's corporate website, SEC filings, investor presentations and featured press releases, both from Cytos Biotechnology AG and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Cytos Biotechnology AG - Brief Cytos Biotechnology AG overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Cytos Biotechnology AG

human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Cytos Biotechnology AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Cytos Biotechnology AG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468525_cytos_biotechnology_ag_product_pipeli ..


Reasons to buy

* Evaluate Cytos Biotechnology AG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Cytos Biotechnology AG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Cytos Biotechnology AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Cytos Biotechnology AG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Cytos Biotechnology AG and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Cytos Biotechnology AG Snapshot
Cytos Biotechnology AG Overview
Key Information
Key Facts
Cytos Biotechnology AG - Research and Development Overview
Key Therapeutic Areas
Cytos Biotechnology AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Cytos Biotechnology AG - Pipeline Products Glance
Cytos Biotechnology AG Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Cytos Biotechnology AG - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Cytos Biotechnology AG - Drug Profiles
CYT-003-QbG10
Product Description
Mechanism of Action
R&D Progress
CYT-017-IL17Qb
Product Description
Mechanism of Action
R&D Progress
CYT-018-IL1aQb
Product Description
Mechanism of Action
R&D Progress
CYT-020-TNFQb
Product Description
Mechanism of Action
R&D Progress
Influenza vaccine Qb-Flu
Product Description
Mechanism of Action
R&D Progress
Cytos Biotechnology AG - Pipeline Products by Route of Administration
Cytos Biotechnology AG - Pipeline Products By Mechanism of Action
Cytos Biotechnology AG - Recent Pipeline Updates
Cytos Biotechnology AG - Dormant Projects
Cytos Biotechnology AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Malaria Vaccine
Cytos Biotechnology AG - Company Statement
Cytos Biotechnology AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Cytos Biotechnology AG, Recent Developments
Cytos Biotechnology AG- Press Release
Nov 11, 2009: Cytos Biotechnology Updates On The Development Of The Hypertension Vaccine CYT006-AngQb.
Jul 31, 2009: Cytos Announces CYT003-QbG10 Phase IIb Study Results For Treatment Of Allergic Rhinoconjunctivitis
Jun 24, 2009: Biotechnology Reports Biochemical Findings From Phase IIa Study With Hypertension Vaccine CYT006-AngQb
Jun 11, 2009: Cytos Biotechnology Initiates Combined Phase I Study With Anti-Interleukin-1 Beta Vaccine CYT013-IL1bQb In Patients With Type II Diabetes
Apr 21, 2009: Cytos Initiates Phase IIa Study With CYT003-QbG10 In Patients With Allergic Asthma Bronchiale
Mar 17, 2009: Cytos Biotechnology Announces Alignment Of Resources Following Setback In The Development Of Its Hypertension Vaccine CYT006-AngQb
Jan 13, 2009: Cytos Reports Six Month Follow-Up Data From Phase II Study With CYT003-QbG10 For Treatment Of Allergic Diseases
Financial Deals Landscape
Cytos Biotechnology AG, Deals Summary
Cytos Biotechnology AG, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Cytos Biotech Enters Into Research And Development Agreement With Walter Reed Army Institute
Cytos Biotech Extends Collaboration Agreement With Agency For Science, Technology And Research
Cytos Biotech Enters Into Collaboration Agreement With Agency For Science, Technology And Research
Cytos Biotech Enters Into Co-Development Agreement With Pfizer Vaccines
Licensing Agreements
Cytos Biotech Enters Into Licensing Agreement With Pfizer
Equity Offering
Cytos Biotechnology Completes Rights Offering Of Shares For $3.5 Million

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468525&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.